Skip to content

A study on the observation of changes in brain activity using NIRSIT (OBI Lab, Korea) in the simultaneous treatment of intradermal acupuncture and central nervous system developmental rehabilitation therapy in patients with cerebral palsy (preliminary study)

A study on the observation of changes in brain activity using NIRSIT (OBI Lab, Korea) in the simultaneous treatment of intradermal acupuncture and central nervous system developmental rehabilitation therapy in patients with cerebral palsy (preliminary study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005984
Enrollment
3
Registered
2021-03-10
Start date
2020-12-30
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : The subject of the study visited once for intervention and performed central nervous system development rehabilitation treatment for 30 minutes at the pediatric exe

Sponsors

Dongguk University Ilsan Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? When the parent or legal representative of the clinical trial subject signs a written consent after hearing the explanation of the purpose, method, and effect of this clinical trial ? Children under 7 years of age diagnosed with cerebral palsy ? Children with developmental delay (if there is a developmental delay in more than one area, such as large movement, small movement, language, and cognition in the standardized developmental test) ? Subjects with no health problems as a result of medical history and physical examination

Exclusion criteria

Exclusion criteria: ? When chromosomal abnormalities or metabolic abnormalities are confirmed ? In case of severe allergic reaction due to intradermal needle or inability to maintain the procedure ? If surgery and hospitalization were performed within the last 3 months ? If there is a change in the dose of anticonvulsant and anticonvulsant drugs within the last 3 months ? If it is difficult to perform rehabilitation treatment with NIRSIT ? If you are currently participating in another clinical trial or plan to participate in another clinical trial during the trial period ? Other cases where the test manager or test manager determines that it is inappropriate

Design outcomes

Primary

MeasureTime frame
Functional near-infrared spectroscopy; fNIRS

Secondary

MeasureTime frame
Check if the device can be worn

Countries

Korea, Republic of

Contacts

Public ContactJIHYUN

Dongguk University Ilsan Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026